181 related articles for article (PubMed ID: 34529182)
1. Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale.
Mulia EPB; Luke K
Egypt Heart J; 2021 Sep; 73(1):82. PubMed ID: 34529182
[TBL] [Abstract][Full Text] [Related]
2. Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial.
Haeberle HA; Calov S; Martus P; Serna-Higuita LM; Koeppen M; Goll A; Bernard A; Zarbock A; Meersch M; Weiss R; Mehrländer M; Marx G; Putensen C; Bakchoul T; Magunia H; Nieswandt B; Mirakaj V; Rosenberger P
Respir Res; 2023 Feb; 24(1):58. PubMed ID: 36805707
[TBL] [Abstract][Full Text] [Related]
3. The role of inhaled prostacyclin in treating acute respiratory distress syndrome.
Searcy RJ; Morales JR; Ferreira JA; Johnson DW
Ther Adv Respir Dis; 2015 Dec; 9(6):302-12. PubMed ID: 26294418
[TBL] [Abstract][Full Text] [Related]
4. Comparison of inhaled nitric oxide with aerosolized prostacyclin or analogues for the postoperative management of pulmonary hypertension: a systematic review and meta-analysis.
Chen SH; Chen LK; Teng TH; Chou WH
Ann Med; 2020; 52(3-4):120-130. PubMed ID: 32204626
[No Abstract] [Full Text] [Related]
5. Prostacyclin for pulmonary arterial hypertension.
Barnes H; Yeoh HL; Fothergill T; Burns A; Humbert M; Williams T
Cochrane Database Syst Rev; 2019 May; 5(5):CD012785. PubMed ID: 31042010
[TBL] [Abstract][Full Text] [Related]
6. Comparison of inhaled milrinone, nitric oxide and prostacyclin in acute respiratory distress syndrome.
Albert M; Corsilli D; Williamson DR; Brosseau M; Bellemare P; Delisle S; Nguyen AQ; Varin F
World J Crit Care Med; 2017 Feb; 6(1):74-78. PubMed ID: 28224110
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Continuous Inhaled Epoprostenol in the Treatment of Acute Respiratory Distress Syndrome, Including Patients With SARS-CoV-2 Infection.
Niss HL; Mohamed A; Berry TP; Saettele TM; Haines MM; Thomas EL
Ann Pharmacother; 2022 Oct; 56(10):1093-1099. PubMed ID: 35021923
[TBL] [Abstract][Full Text] [Related]
8. A Narrative Review on the Administration of Inhaled Prostaglandins in Critically Ill Adult Patients With Acute Respiratory Distress Syndrome.
Ware LR; Kim CS; Szumita PM; DeGrado JR
Ann Pharmacother; 2024 May; 58(5):533-548. PubMed ID: 37589097
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of Inhaled Epoprostenol in Patients With Acute Respiratory Distress Syndrome and COVID-19-Associated Acute Respiratory Distress Syndrome.
Robinson J; Santarelli A; Wilks N; Latu L; Charran O; Lalitsasivimol D; Dietrich T; Ashurst J
Cureus; 2022 Aug; 14(8):e28274. PubMed ID: 36158384
[TBL] [Abstract][Full Text] [Related]
10. Inhaled Prostacyclins for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.
Torbic H; Saini A; Harnegie MP; Sadana D; Duggal A
Crit Care Explor; 2023 Jun; 5(6):e0931. PubMed ID: 37303944
[TBL] [Abstract][Full Text] [Related]
11. Nebulized prostacyclin (PGI2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response.
Domenighetti G; Stricker H; Waldispuehl B
Crit Care Med; 2001 Jan; 29(1):57-62. PubMed ID: 11176161
[TBL] [Abstract][Full Text] [Related]
12. Inhaled prostanoids in the therapy of pulmonary hypertension.
Gessler T; Seeger W; Schmehl T
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):1-12. PubMed ID: 18518827
[TBL] [Abstract][Full Text] [Related]
13. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
14. Inhaled nitric oxide for the adult respiratory distress syndrome.
Rossaint R; Falke KJ; López F; Slama K; Pison U; Zapol WM
N Engl J Med; 1993 Feb; 328(6):399-405. PubMed ID: 8357359
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
[TBL] [Abstract][Full Text] [Related]
16. Inhaled nitric oxide and inhaled prostacyclin in acute respiratory distress syndrome: what is the evidence?
Puri N; Dellinger RP
Crit Care Clin; 2011 Jul; 27(3):561-87. PubMed ID: 21742217
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
18. Noninferiority of Inhaled Epoprostenol to Inhaled Nitric Oxide for the Treatment of ARDS.
Ammar MA; Bauer SR; Bass SN; Sasidhar M; Mullin R; Lam SW
Ann Pharmacother; 2015 Oct; 49(10):1105-12. PubMed ID: 26187741
[TBL] [Abstract][Full Text] [Related]
19. Aerosolized prostacyclin and inhaled nitric oxide in septic shock--different effects on splanchnic oxygenation?
Eichelbrönner O; Reinelt H; Wiedeck H; Mezödy M; Rossaint R; Georgieff M; Radermacher P
Intensive Care Med; 1996 Sep; 22(9):880-7. PubMed ID: 8905421
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19.
Sonti R; Pike CW; Cobb N
J Intensive Care Med; 2021 Mar; 36(3):327-333. PubMed ID: 33234007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
